title: Comment: comparison of FDA reports of patient deaths associated with sildenafil and injectable alprostadil.
authors.forename: B L
authors.initials: BL
authors.lastname: Strom
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000706:statistics & numerical data*; D000527:Alprostadil / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009026:Mortality; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*; D010879:Piperazines / Q000009:adverse effects*; D011687:Purines; D015203:Reproducibility of Results; D000068677:Sildenafil Citrate; D013450:Sulfones; D014481:United States; D014486:United States Food and Drug Administration; D014665:Vasodilator Agents / Q000009:adverse effects*
chemical_list: D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D000527:Alprostadil